首页 > 最新文献

Revista mexicana de urologia最新文献

英文 中文
Efectos secundarios de los inhibidores de 5-α reductasa en el tratamiento de hiperplasia prostática benigna 5-α还原酶抑制剂治疗前列腺增生症的副作用
Q4 Medicine Pub Date : 2016-09-01 DOI: 10.1016/j.uromx.2016.08.002
A. García-Vega
{"title":"Efectos secundarios de los inhibidores de 5-α reductasa en el tratamiento de hiperplasia prostática benigna","authors":"A. García-Vega","doi":"10.1016/j.uromx.2016.08.002","DOIUrl":"https://doi.org/10.1016/j.uromx.2016.08.002","url":null,"abstract":"","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 5","pages":"Pages 265-266"},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.08.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72267043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bcl2 en cáncer avanzado de próstata y asociación con resistencia a la castración BCL2在晚期前列腺癌中的表达及其与去势耐药性的关系
Q4 Medicine Pub Date : 2016-09-01 DOI: 10.1016/j.uromx.2016.07.001
R.F. Velázquez-Macías , F.E. De La Torre-Rendón , G. Ramos-Rodríguez , C.A. Calzada-Mendoza , R.M. Coral-Vázquez

Introduction and aims

The study of the anti-apoptotic protein, Bcl2, in localized prostate cancer has not been carried out in advanced stages of the disease. Therefore the aim of our study was to evaluate Bcl2 expression in advanced prostate cancer and identify its association with age, body weight, height, body mass index, prostate-specific antigen, testosterone, Gleason score, bone metastasis, disease duration, and time until the appearance of hormone resistance.

Material and method

A comparative study was conducted on 19 patients with castration-resistant prostate cancer (CRPC) and 19 patients with hormone-sensitive prostate cancer (HSPC). Bcl2 was identified in a blinded manner through immunohistochemistry in prostate biopsies.

Results

Prostate-specific antigen was higher in patients with CRPC and disease duration was 39.71 months for CRPC and 23.89 months for HSPC. Resistance appeared at 30.05 months. There were no significant differences in relation to the other variables. Bcl2 was identified in 63.16% of the patients with CRPC and in 84.21% of those with HSPC, odds ratio 0.32, 95% CI: 0.07-1.45. There was mild staining intensity in 47.37% of the CRPC cases and moderate staining in 15.79%. Staining was mild in 57.89% of the HSPC patients and moderate in 26.32%. The differences were not significant. Correlation analysis showed a negative correlation trend between Bcl2 and body weight and a positive trend between Bcl2 and disease duration, with no statistical significance.

Conclusion

Bcl2 was identified in advanced prostate cancer and showed a trend toward greater expression in hormone-sensitive cancer. There was no correlation between Bcl2 and the clinical variables analyzed. However, there was a negative correlation between Bcl2 stain intensity and body weight and a positive trend between Bcl2 and disease duration.

引言和目的对癌症晚期局限性前列腺癌中抗凋亡蛋白Bcl2的研究尚未进行。因此,我们研究的目的是评估Bcl2在晚期癌症中的表达,并确定其与年龄、体重、身高、体重指数、前列腺特异性抗原、睾酮、Gleason评分、骨转移、疾病持续时间和出现激素抵抗的时间的关系。材料与方法对19例去势抵抗性前列腺癌症(CRPC)和19例激素敏感性前列腺癌症(HSPC)患者进行比较研究。Bcl2在前列腺活检中通过免疫组织化学以盲法鉴定。结果CRPC患者前列腺特异性抗原含量较高,CRPC患者病程39.71个月,HSPC患者病程23.89个月。30.05个月出现耐药性。与其他变量相比,没有显著差异。Bcl2在63.16%的CRPC患者和84.21%的HSPC患者中被鉴定,比值比为0.32,95%CI:0.07-1.45。CRPC中47.37%为轻度,15.79%为中度,HSPC中57.89%为轻度,26.32%为中度,差异无统计学意义。相关分析显示Bcl2与体重呈负相关,与病程呈正相关,无统计学意义。结论Bcl2在晚期癌症中有表达,在激素敏感性癌症中有表达增加的趋势。Bcl2与分析的临床变量之间没有相关性。然而,Bcl2染色强度与体重呈负相关,Bcl2与疾病持续时间呈正相关。
{"title":"Bcl2 en cáncer avanzado de próstata y asociación con resistencia a la castración","authors":"R.F. Velázquez-Macías ,&nbsp;F.E. De La Torre-Rendón ,&nbsp;G. Ramos-Rodríguez ,&nbsp;C.A. Calzada-Mendoza ,&nbsp;R.M. Coral-Vázquez","doi":"10.1016/j.uromx.2016.07.001","DOIUrl":"https://doi.org/10.1016/j.uromx.2016.07.001","url":null,"abstract":"<div><h3>Introduction and aims</h3><p>The study of the anti-apoptotic protein, Bcl2, in localized prostate cancer has not been carried out in advanced stages of the disease. Therefore the aim of our study was to evaluate Bcl2 expression in advanced prostate cancer and identify its association with age, body weight, height, body mass index, prostate-specific antigen, testosterone, Gleason score, bone metastasis, disease duration, and time until the appearance of hormone resistance.</p></div><div><h3>Material and method</h3><p>A comparative study was conducted on 19 patients with castration-resistant prostate cancer (CRPC) and 19 patients with hormone-sensitive prostate cancer (HSPC). Bcl2 was identified in a blinded manner through immunohistochemistry in prostate biopsies.</p></div><div><h3>Results</h3><p>Prostate-specific antigen was higher in patients with CRPC and disease duration was 39.71 months for CRPC and 23.89 months for HSPC. Resistance appeared at 30.05 months. There were no significant differences in relation to the other variables. Bcl2 was identified in 63.16% of the patients with CRPC and in 84.21% of those with HSPC, odds ratio 0.32, 95% CI: 0.07-1.45. There was mild staining intensity in 47.37% of the CRPC cases and moderate staining in 15.79%. Staining was mild in 57.89% of the HSPC patients and moderate in 26.32%. The differences were not significant. Correlation analysis showed a negative correlation trend between Bcl2 and body weight and a positive trend between Bcl2 and disease duration, with no statistical significance.</p></div><div><h3>Conclusion</h3><p>Bcl2 was identified in advanced prostate cancer and showed a trend toward greater expression in hormone-sensitive cancer. There was no correlation between Bcl2 and the clinical variables analyzed. However, there was a negative correlation between Bcl2 stain intensity and body weight and a positive trend between Bcl2 and disease duration.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 5","pages":"Pages 288-293"},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.07.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72267036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Abordaje laparoscópico para el tratamiento quirúrgico de los tumores renales y del tracto urinario superior 腹腔镜手术治疗肾和上尿路肿瘤
Q4 Medicine Pub Date : 2016-09-01 DOI: 10.1016/j.uromx.2016.06.002
J.A. Rivera-Ramírez, J.J. Cendejas-Gómez, B. Gabilondo-Pliego, F. Rodríguez-Covarrubias

Introduction

Laparoscopy is currently one of the options for the surgical treatment of kidney tumors and upper urinary tract tumors with oncologic results that are similar to those of open surgery.

Aim

To describe the experience in the laparoscopic treatment of kidney and upper urinary tract tumors at our hospital.

Materials and methods

A retrospective and descriptive study was conducted, analyzing the database of patients with kidney or upper urinary tract tumors treated through the laparoscopic procedures of nephrectomy (radical or partial) or nephroureterectomy within the time frame of August 2006 and June 2015. Radiologic and histopathologic variables were analyzed, along with the frequency of complications (Clavien-Dindo classification).

Results

Ninety-six patients were identified that underwent the laparoscopic approach. Fifty-eight radical nephrectomies, 24 partial nephrectomies, and 14 nephroureterectomies were performed. The conversion rate was 16.6% and the mean hospital stay was 5 days. Grade IIIa and IVa complications presented in 9.3% of the cases. The mean follow-up period was 31.2 months and only one patient has died, due to leukemia.

Conclusions

We consider the laparoscopic approach to be a good treatment option for kidney tumors and upper urinary tract tumors.

引言腹腔镜是目前肾脏肿瘤和上尿路肿瘤的手术治疗选择之一,其肿瘤学结果与开放手术相似。目的介绍我院腹腔镜治疗肾及上尿路肿瘤的经验。材料和方法进行了一项回顾性和描述性研究,分析了2006年8月至2015年6月期间通过腹腔镜肾切除术(根治性或部分)或肾输尿管切除术治疗的肾或上尿路肿瘤患者的数据库。分析放射学和组织病理学变量,以及并发症的发生频率(Clavien-Dindo分类)。结果96例患者采用腹腔镜入路。共进行了58例根治性肾切除术、24例部分肾切除术和14例肾输尿管切除术。转化率为16.6%,平均住院时间为5天。9.3%的病例出现IIIa和IVa级并发症。平均随访期为31.2个月,只有一名患者死于白血病。结论腹腔镜入路是治疗肾肿瘤和上尿路肿瘤的良好方法。
{"title":"Abordaje laparoscópico para el tratamiento quirúrgico de los tumores renales y del tracto urinario superior","authors":"J.A. Rivera-Ramírez,&nbsp;J.J. Cendejas-Gómez,&nbsp;B. Gabilondo-Pliego,&nbsp;F. Rodríguez-Covarrubias","doi":"10.1016/j.uromx.2016.06.002","DOIUrl":"https://doi.org/10.1016/j.uromx.2016.06.002","url":null,"abstract":"<div><h3>Introduction</h3><p>Laparoscopy is currently one of the options for the surgical treatment of kidney tumors and upper urinary tract tumors with oncologic results that are similar to those of open surgery.</p></div><div><h3>Aim</h3><p>To describe the experience in the laparoscopic treatment of kidney and upper urinary tract tumors at our hospital.</p></div><div><h3>Materials and methods</h3><p>A retrospective and descriptive study was conducted, analyzing the database of patients with kidney or upper urinary tract tumors treated through the laparoscopic procedures of nephrectomy (radical or partial) or nephroureterectomy within the time frame of August 2006 and June 2015. Radiologic and histopathologic variables were analyzed, along with the frequency of complications (Clavien-Dindo classification).</p></div><div><h3>Results</h3><p>Ninety-six patients were identified that underwent the laparoscopic approach. Fifty-eight radical nephrectomies, 24 partial nephrectomies, and 14 nephroureterectomies were performed. The conversion rate was 16.6% and the mean hospital stay was 5 days. Grade IIIa and IVa complications presented in 9.3% of the cases. The mean follow-up period was 31.2 months and only one patient has died, due to leukemia.</p></div><div><h3>Conclusions</h3><p>We consider the laparoscopic approach to be a good treatment option for kidney tumors and upper urinary tract tumors.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 5","pages":"Pages 279-283"},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.06.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72267041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Trans-splenic puncture during percutaneous nephrolithotomy: Outcome spectrum of the same complication 经皮肾镜取石术中经脾穿刺:相同并发症的预后谱
Q4 Medicine Pub Date : 2016-09-01 DOI: 10.1016/j.uromx.2016.06.007
R. Ugalde-Resano , B. Montaño-Roca , G. Montiel-Ugalde, J.A. Varela-Prieto, D. Olvera-Posada, C.E. Méndez-Probst

Percutaneous nephrolithotomy is an endourologic technique commonly used in the management of nephrolithiasis. However, this procedure is not complication-free. Splenic injury is exceptionally rare with a reported rate of 1% from the total case load. We present herein two cases of splenic puncture during percutaneous nephrolithotomy that illustrate two different outcomes. In the first case, the patient remained asymptomatic and was discharged on her third post-operative day after removing the nephrostomy, without any sign of hemodynamic compromise. In the second case, the patient presented with hemodynamic instability and an abdominal computed tomography scan was done that showed free fluid in the peritoneal cavity. Emergency laparotomy was performed and revealed a deep peripheral laceration (20 mm × 5 mm in length) that required splenectomy. After a thorough review of the existing literature, we could find only 11 other instances of injury to the spleen in which treatment outcomes were reported. Patient hemodynamic status was the main factor in deciding on the type of treatment.

经皮肾镜取石术是一种常用于治疗肾结石的泌尿道技术。然而,这一过程并非没有并发症。脾损伤是非常罕见的报道率为1%的总病例负荷。我们在此报告两个经皮肾镜取石术中脾穿刺的病例,说明两种不同的结果。第一例患者无症状,在切除肾造口术后第三天出院,没有任何血流动力学受损的迹象。在第二个病例中,患者表现为血流动力学不稳定,腹部计算机断层扫描显示腹腔内有游离液体。急诊开腹手术发现深部外周撕裂伤(长度为20mm × 5mm),需要脾切除术。在对现有文献进行全面回顾后,我们只能找到11例其他脾脏损伤的治疗结果报告。患者血流动力学状态是决定治疗方式的主要因素。
{"title":"Trans-splenic puncture during percutaneous nephrolithotomy: Outcome spectrum of the same complication","authors":"R. Ugalde-Resano ,&nbsp;B. Montaño-Roca ,&nbsp;G. Montiel-Ugalde,&nbsp;J.A. Varela-Prieto,&nbsp;D. Olvera-Posada,&nbsp;C.E. Méndez-Probst","doi":"10.1016/j.uromx.2016.06.007","DOIUrl":"10.1016/j.uromx.2016.06.007","url":null,"abstract":"<div><p>Percutaneous nephrolithotomy is an endourologic technique commonly used in the management of nephrolithiasis. However, this procedure is not complication-free. Splenic injury is exceptionally rare with a reported rate of 1% from the total case load. We present herein two cases of splenic puncture during percutaneous nephrolithotomy that illustrate two different outcomes. In the first case, the patient remained asymptomatic and was discharged on her third post-operative day after removing the nephrostomy, without any sign of hemodynamic compromise. In the second case, the patient presented with hemodynamic instability and an abdominal computed tomography scan was done that showed free fluid in the peritoneal cavity. Emergency laparotomy was performed and revealed a deep peripheral laceration (20<!--> <!-->mm<!--> <!-->×<!--> <!-->5<!--> <!-->mm in length) that required splenectomy. After a thorough review of the existing literature, we could find only 11 other instances of injury to the spleen in which treatment outcomes were reported. Patient hemodynamic status was the main factor in deciding on the type of treatment.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 5","pages":"Pages 319-322"},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.06.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132273721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Factores asociados con la respuesta a la terapia de privación androgénica en pacientes con cáncer de próstata y metástasis óseas en una institución 前列腺癌和骨转移患者对雄激素剥夺治疗反应的相关因素
Q4 Medicine Pub Date : 2016-09-01 DOI: 10.1016/j.uromx.2016.05.005
V. Cornejo-Dávila , G.S. García-de la Torre , M.A. Palmeros-Rodríguez , I. Uberetagoyena-Tello de Meneses , J.E. Sedano-Basilio , L. Trujillo-Ortiz , J. Gómez-Sánchez , J.A. Herrera-Muñoz , D.A. Preciado-Estrella , N. Olavarría-Sayavedra , M. Cantellano-Orozco , G. Fernández-Noyola , C. Martínez-Arroyo , J.G. Morales-Montor , C. Pacheco-Gahbler

Background

Metastatic prostate cancer is a frequent disease in Mexico. There are factors that can be associated with an adequate response to androgen deprivation therapy. Other therapeutic regimens have been proposed to improve results.

Aim

To identify factors influencing the response to androgen deprivation therapy in patients with prostate cancer and bone metastases.

Materials and methods

The study covered a 7-year period and included patients that presented with metastatic prostate cancer. Patient factors were evaluated during androgen deprivation therapy and follow-up. The association between factors and response was assessed through bivariate and multivariate analyses.

Results

Eighty-nine patients were included in the study. The factors associated with the development of castration resistance were: age, Gleason score, prostate-specific antigen reduction > 95%, less than 9 months to reach the nadir, and androgen deprivation therapy duration. Having received palliative radiotherapy and periods of intermittence were the factors that were contrastingly associated with cancer-specific mortality. Other factors related to prostate-specific antigen kinetics were not statistically significant in the multivariate analysis.

Conclusions

The described factors were associated with the response to androgen deprivation therapy in patients with metastatic prostate cancer.

背景转移性癌症是墨西哥的常见疾病。有一些因素可能与雄激素剥夺治疗的充分反应有关。已经提出了其他治疗方案来改善结果。目的探讨影响癌症骨转移患者雄激素剥夺治疗反应的因素。材料和方法本研究历时7年,研究对象为癌症转移患者。在雄激素剥夺治疗和随访期间评估患者因素。通过双变量和多变量分析来评估因素与反应之间的相关性。结果89例患者被纳入研究。与去势抵抗发展相关的因素是:年龄、Gleason评分、前列腺特异性抗原减少>;95%,不到9个月达到最低点,雄激素剥夺治疗持续时间。接受姑息性放疗和间歇期是与癌症特异性死亡率相反相关的因素。在多变量分析中,与前列腺特异性抗原动力学相关的其他因素没有统计学意义。结论上述因素和转移性前列腺癌症患者雄激素剥夺治疗的反应有关。
{"title":"Factores asociados con la respuesta a la terapia de privación androgénica en pacientes con cáncer de próstata y metástasis óseas en una institución","authors":"V. Cornejo-Dávila ,&nbsp;G.S. García-de la Torre ,&nbsp;M.A. Palmeros-Rodríguez ,&nbsp;I. Uberetagoyena-Tello de Meneses ,&nbsp;J.E. Sedano-Basilio ,&nbsp;L. Trujillo-Ortiz ,&nbsp;J. Gómez-Sánchez ,&nbsp;J.A. Herrera-Muñoz ,&nbsp;D.A. Preciado-Estrella ,&nbsp;N. Olavarría-Sayavedra ,&nbsp;M. Cantellano-Orozco ,&nbsp;G. Fernández-Noyola ,&nbsp;C. Martínez-Arroyo ,&nbsp;J.G. Morales-Montor ,&nbsp;C. Pacheco-Gahbler","doi":"10.1016/j.uromx.2016.05.005","DOIUrl":"https://doi.org/10.1016/j.uromx.2016.05.005","url":null,"abstract":"<div><h3>Background</h3><p>Metastatic prostate cancer is a frequent disease in Mexico. There are factors that can be associated with an adequate response to androgen deprivation therapy. Other therapeutic regimens have been proposed to improve results.</p></div><div><h3>Aim</h3><p>To identify factors influencing the response to androgen deprivation therapy in patients with prostate cancer and bone metastases.</p></div><div><h3>Materials and methods</h3><p>The study covered a 7-year period and included patients that presented with metastatic prostate cancer. Patient factors were evaluated during androgen deprivation therapy and follow-up. The association between factors and response was assessed through bivariate and multivariate analyses.</p></div><div><h3>Results</h3><p>Eighty-nine patients were included in the study. The factors associated with the development of castration resistance were: age, Gleason score, prostate-specific antigen reduction<!--> <!-->&gt;<!--> <!-->95%, less than 9 months to reach the nadir, and androgen deprivation therapy duration. Having received palliative radiotherapy and periods of intermittence were the factors that were contrastingly associated with cancer-specific mortality. Other factors related to prostate-specific antigen kinetics were not statistically significant in the multivariate analysis.</p></div><div><h3>Conclusions</h3><p>The described factors were associated with the response to androgen deprivation therapy in patients with metastatic prostate cancer.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 5","pages":"Pages 267-274"},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.05.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72267044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plastia ureteropiélica robot asistida más litolapaxia simultánea con cistoscopia flexible transtrocar 机器人辅助输尿管成形术加上同时结石治疗与transtrocar柔性膀胱镜检查
Q4 Medicine Pub Date : 2016-09-01 DOI: 10.1016/j.uromx.2016.07.003
V.E. Corona-Montes , S. II García-Nares , A. Rueda-Loaiza , L.F. Quinzaños-Sordo , J.A. Zapata-González

Introduction

Pyeloplasty has been described by different authors and taken into minimally invasive surgery through laparoscopy, becoming the criterion standard of the procedure. Today its laparoscopic results are similar to those with the open technique, but the former requires much more experience and skill. When performed through robotic-assisted surgery, this minimally invasive procedure has the potential to more easily manipulate intracorporeal suturing and combine trans-trocar cystoscopy for litholapaxy.

Materials and methods

A 32-year-old man presented with colicky, left lumbar pain of moderate intensity with associated urinary symptoms and positive costovertebral angle percussion. An abdominopelvic tomography scan revealed ureteropelvic junction stricture and a pelvic stone measuring 1.3 cm.

Discussion

Robotic-assisted pyeloplasty was first described in 2002 by Gettman and its success rates are similar to those of other techniques.

Conclusions

Robotic-assisted pyeloplasty is a good alternative technique for defect suturing and repair. It can also be a hybrid surgery through its combination with trans-trocar endoscopy to simultaneously perform litholapaxy of the renal pelvis or renal cavities.

肾盂成形术已被不同的作者描述,并通过腹腔镜纳入微创手术,成为该手术的标准。如今,腹腔镜手术的结果与开放式手术相似,但前者需要更多的经验和技能。当通过机器人辅助手术进行时,这种微创手术具有更容易操作体内缝合和结合经套管穿刺膀胱镜进行结石清除的潜力。材料与方法男性32岁,以腰绞痛、左腰疼痛为主诉,伴尿路症状,肋椎角叩击阳性。腹部肾盂断层扫描显示输尿管肾盂连接处狭窄,骨盆结石直径1.3厘米。机器人辅助肾盂成形术于2002年由Gettman首次描述,其成功率与其他技术相似。结论机器人辅助肾盂成形术是一种很好的修复肾盂缺损的方法。它也可以是一种混合手术,通过它与经套管针内窥镜的结合,同时进行肾盂或肾腔的结石清除。
{"title":"Plastia ureteropiélica robot asistida más litolapaxia simultánea con cistoscopia flexible transtrocar","authors":"V.E. Corona-Montes ,&nbsp;S. II García-Nares ,&nbsp;A. Rueda-Loaiza ,&nbsp;L.F. Quinzaños-Sordo ,&nbsp;J.A. Zapata-González","doi":"10.1016/j.uromx.2016.07.003","DOIUrl":"10.1016/j.uromx.2016.07.003","url":null,"abstract":"<div><h3>Introduction</h3><p>Pyeloplasty has been described by different authors and taken into minimally invasive surgery through laparoscopy, becoming the criterion standard of the procedure. Today its laparoscopic results are similar to those with the open technique, but the former requires much more experience and skill. When performed through robotic-assisted surgery, this minimally invasive procedure has the potential to more easily manipulate intracorporeal suturing and combine trans-trocar cystoscopy for litholapaxy.</p></div><div><h3>Materials and methods</h3><p>A 32-year-old man presented with colicky, left lumbar pain of moderate intensity with associated urinary symptoms and positive costovertebral angle percussion. An abdominopelvic tomography scan revealed ureteropelvic junction stricture and a pelvic stone measuring 1.3<!--> <!-->cm.</p></div><div><h3>Discussion</h3><p>Robotic-assisted pyeloplasty was first described in 2002 by Gettman and its success rates are similar to those of other techniques.</p></div><div><h3>Conclusions</h3><p>Robotic-assisted pyeloplasty is a good alternative technique for defect suturing and repair. It can also be a hybrid surgery through its combination with trans-trocar endoscopy to simultaneously perform litholapaxy of the renal pelvis or renal cavities.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 5","pages":"Pages 327-330"},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.07.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128057110","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resección laparoscópica de pólipo fibroepitelial ureteral. Reporte de caso del Hospital General de México «Dr. Eduardo Liceaga» 腹腔镜切除输尿管纤维上皮息肉。墨西哥总医院病例报告«Dr。Eduardo Liceaga»
Q4 Medicine Pub Date : 2016-09-01 DOI: 10.1016/j.uromx.2016.06.003
A. Cumming, V.E. Corona Montes, J. Monjaras Guerra, J. Rodríguez Robles, J.E. Rosas Nava

Introduction

The incidence of primary tumors of the ureter is <1% and fibroepithelial polyps make up 20% of them. These polyps are related to chronic inflammation, chronic damage, or chronic stimulation. They are asymptomatic and can cause obstructive uropathy or hematuria.

Aim

To present a case of fibroepithelial polyp managed laparoscopically at the Hospital General de México «Dr. Eduardo Liceaga».

Materials and methods

A 46-year-old woman had oppressive pain of moderate intensity in the right renal fossa irradiating to the iliac fossa of 4-year progression. She presented with dysuria and intermittent total hematuria with no clots. A tomography scan revealed mild right pelvic ectasia and a filling defect at the lower third of the ureter. Endoscopic revision found a ureteral lesion with a pedunculated base 8 cm from the right ureteral meatus. The pathology report stated fibroepithelial polyp. The polyp was laparoscopically resected, end-to-end anastomosis was performed, and a double-J ureteral stent was placed.

Results

The case of a patient that underwent laparoscopic treatment of a fibroepithelial polyp is presented.

Discussion

Few cases of fibroepithelial polyp have been treated laparoscopically. In 2011 Jin Xun-Bo et al. reported on a case of laparoscopic resolution of a ureteral fibroepithelial polyp and in 2009 M.A. Childs conducted a review of their clinical database at the Mayo Clinic within the time frame of 1945-2008 in which 27 cases of ureteral fibroepithelial polyp were identified.

Conclusion

Laparoscopy offers a satisfactory approach for resection of ureteral fibroepithelial polyps.

输尿管原发肿瘤发生率为1%,纤维上皮性息肉占20%。这些息肉与慢性炎症、慢性损伤或慢性刺激有关。它们无症状,可引起梗阻性尿病或血尿。目的:报告一例纤维上皮性息肉在梅萨西总医院腹腔镜治疗的病例。爱德华多Liceaga»。材料与方法一例46岁女性患者,右侧肾窝压迫性疼痛,中度,向髂窝放射,病情进展4年。患者表现为排尿困难和间歇性全血尿,无血块。断层扫描显示轻度右侧盆腔扩张和输尿管下三分之一充盈缺损。内镜检查发现输尿管病变,底部有带蒂,距右侧输尿管道8厘米。病理报告为纤维上皮性息肉。腹腔镜切除息肉,端对端吻合,放置双j输尿管支架。结果一例患者接受腹腔镜治疗的纤维上皮息肉是提出。很少有纤维上皮性息肉在腹腔镜下治疗。2011年,Jin xon - bo等人报道了一例输尿管纤维上皮息肉的腹腔镜解决方案。2009年,M.A. Childs回顾了他们在Mayo诊所1945-2008年期间的临床数据库,其中发现了27例输尿管纤维上皮息肉。结论腹腔镜手术治疗输尿管纤维上皮息肉是一种满意的手术方法。
{"title":"Resección laparoscópica de pólipo fibroepitelial ureteral. Reporte de caso del Hospital General de México «Dr. Eduardo Liceaga»","authors":"A. Cumming,&nbsp;V.E. Corona Montes,&nbsp;J. Monjaras Guerra,&nbsp;J. Rodríguez Robles,&nbsp;J.E. Rosas Nava","doi":"10.1016/j.uromx.2016.06.003","DOIUrl":"10.1016/j.uromx.2016.06.003","url":null,"abstract":"<div><h3>Introduction</h3><p>The incidence of primary tumors of the ureter is &lt;1% and fibroepithelial polyps make up 20% of them. These polyps are related to chronic inflammation, chronic damage, or chronic stimulation. They are asymptomatic and can cause obstructive uropathy or hematuria.</p></div><div><h3>Aim</h3><p>To present a case of fibroepithelial polyp managed laparoscopically at the <em>Hospital General de México «Dr. Eduardo Liceaga».</em></p></div><div><h3>Materials and methods</h3><p>A 46-year-old woman had oppressive pain of moderate intensity in the right renal fossa irradiating to the iliac fossa of 4-year progression. She presented with dysuria and intermittent total hematuria with no clots. A tomography scan revealed mild right pelvic ectasia and a filling defect at the lower third of the ureter. Endoscopic revision found a ureteral lesion with a pedunculated base 8<!--> <!-->cm from the right ureteral meatus. The pathology report stated fibroepithelial polyp. The polyp was laparoscopically resected, end-to-end anastomosis was performed, and a double-J ureteral stent was placed.</p></div><div><h3>Results</h3><p>The case of a patient that underwent laparoscopic treatment of a fibroepithelial polyp is presented.</p></div><div><h3>Discussion</h3><p>Few cases of fibroepithelial polyp have been treated laparoscopically. In 2011 Jin Xun-Bo et al. reported on a case of laparoscopic resolution of a ureteral fibroepithelial polyp and in 2009 M.A. Childs conducted a review of their clinical database at the Mayo Clinic within the time frame of 1945-2008 in which 27 cases of ureteral fibroepithelial polyp were identified.</p></div><div><h3>Conclusion</h3><p>Laparoscopy offers a satisfactory approach for resection of ureteral fibroepithelial polyps.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 5","pages":"Pages 315-318"},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.06.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134151600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fe de errores de «Resultados obtenidos con nefrolitotomía percutánea y su correlación con las escalas de Guy y S.T.O.N.E. en un hospital de la Ciudad de México» 《墨西哥城一家医院经皮肾石切开术结果及其与Guy和S.T.O.N.E.量表的相关性》的错误Fe
Q4 Medicine Pub Date : 2016-09-01 DOI: 10.1016/j.uromx.2016.08.004
J. Gómez-Sánchez, C. Martínez-Arroyo, M. Cantellano-Orozco, J.G. Morales-Montor, G. Fernández-Noyola, C. Pacheco-Gahbler, V. Cornejo-Dávila, J.A. Herrera-Muñoz, D.A. Preciado-Estrella
{"title":"Fe de errores de «Resultados obtenidos con nefrolitotomía percutánea y su correlación con las escalas de Guy y S.T.O.N.E. en un hospital de la Ciudad de México»","authors":"J. Gómez-Sánchez,&nbsp;C. Martínez-Arroyo,&nbsp;M. Cantellano-Orozco,&nbsp;J.G. Morales-Montor,&nbsp;G. Fernández-Noyola,&nbsp;C. Pacheco-Gahbler,&nbsp;V. Cornejo-Dávila,&nbsp;J.A. Herrera-Muñoz,&nbsp;D.A. Preciado-Estrella","doi":"10.1016/j.uromx.2016.08.004","DOIUrl":"10.1016/j.uromx.2016.08.004","url":null,"abstract":"","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 5","pages":"Page 331"},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.08.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126921609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radioterapia externa en el tratamiento del cáncer de la próstata: experiencia personal 1993-2015 前列腺癌治疗中的体外放射治疗:1993-2015年的个人经验
Q4 Medicine Pub Date : 2016-09-01 DOI: 10.1016/j.uromx.2016.05.006
E. Zonana-Farca , A. Sedano-Lozano , E.A. Ramirez-Perez , A. Zárate-Osorno , M. García-Sáenz , A. Lozano-Zalce

Background

In this work the changes in and evolution of radiotherapy for the treatment of prostate cancer in the last decades are described. This includes the application of advanced technology that incorporates imaging and computer systems into the new linear accelerators designed to apply high doses of radiation to the prostate, significantly diminishing the toxicity to the surrounding tissues.

Aims

Results found in the international literature are analyzed that consider increasing the radiation doses with the 3D-CRT and IMRT techniques, and in this manner improve biochemical failure-free survival and overall survival, especially in intermediate and high-risk patients with clinically localized prostate cancer, as well as adding radiotherapy and neoadjuvant, concomitant, and adjuvant hormone therapy.

Materials and methods

Presented herein is the personal experience that included 38 patients with clinically localized prostate cancer treated in private practice with external beam radiotherapy and hormone therapy as primary treatment, as well as the experience including 46 patients with pT3 disease after radical prostatectomy that received adjuvant treatments of radiotherapy and hormone therapy.

Results

Even though this clinical study includes a small number of patients, to the best of our knowledge it is the first and only report in the national literature on the use and benefits of the combined treatment of external beam radiotherapy and hormone therapy as primary treatment of clinically localized prostate cancer and as combined adjuvant treatment in patients with pT3 disease after radical prostatectomy.

背景本文介绍了近几十年来癌症放射治疗的变化和发展。这包括将成像和计算机系统集成到新型线性加速器中的先进技术的应用,该加速器旨在向前列腺施加高剂量的辐射,显著降低对周围组织的毒性。目的分析国际文献中发现的结果,考虑使用3D-CRT和IMRT技术增加辐射剂量,并通过这种方式提高生物化学无故障生存率和总生存率,特别是在临床上局限性前列腺癌症的中高风险患者中,以及辅助激素治疗。材料和方法本文提供的是包括38名临床局限性前列腺癌症患者在私人诊所接受外束放射治疗和激素治疗作为主要治疗的个人经历,以及包括46名前列腺癌根治术后接受放疗和激素治疗辅助治疗的pT3患者的经历。结果尽管本次临床研究包括少量患者,据我们所知,这是国内文献中第一篇也是唯一一篇关于外束放疗和激素治疗联合治疗临床局限性前列腺癌症的初级治疗和根治性前列腺切除术后pT3疾病患者的联合辅助治疗的使用和益处的报道。
{"title":"Radioterapia externa en el tratamiento del cáncer de la próstata: experiencia personal 1993-2015","authors":"E. Zonana-Farca ,&nbsp;A. Sedano-Lozano ,&nbsp;E.A. Ramirez-Perez ,&nbsp;A. Zárate-Osorno ,&nbsp;M. García-Sáenz ,&nbsp;A. Lozano-Zalce","doi":"10.1016/j.uromx.2016.05.006","DOIUrl":"https://doi.org/10.1016/j.uromx.2016.05.006","url":null,"abstract":"<div><h3>Background</h3><p>In this work the changes in and evolution of radiotherapy for the treatment of prostate cancer in the last decades are described. This includes the application of advanced technology that incorporates imaging and computer systems into the new linear accelerators designed to apply high doses of radiation to the prostate, significantly diminishing the toxicity to the surrounding tissues.</p></div><div><h3>Aims</h3><p>Results found in the international literature are analyzed that consider increasing the radiation doses with the 3D-CRT and IMRT techniques, and in this manner improve biochemical failure-free survival and overall survival, especially in intermediate and high-risk patients with clinically localized prostate cancer, as well as adding radiotherapy and neoadjuvant, concomitant, and adjuvant hormone therapy.</p></div><div><h3>Materials and methods</h3><p>Presented herein is the personal experience that included 38 patients with clinically localized prostate cancer treated in private practice with external beam radiotherapy and hormone therapy as primary treatment, as well as the experience including 46 patients with pT3 disease after radical prostatectomy that received adjuvant treatments of radiotherapy and hormone therapy.</p></div><div><h3>Results</h3><p>Even though this clinical study includes a small number of patients, to the best of our knowledge it is the first and only report in the national literature on the use and benefits of the combined treatment of external beam radiotherapy and hormone therapy as primary treatment of clinically localized prostate cancer and as combined adjuvant treatment in patients with pT3 disease after radical prostatectomy.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 5","pages":"Pages 298-310"},"PeriodicalIF":0.0,"publicationDate":"2016-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.05.006","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72267039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Tuberculosis primaria de la próstata. Reporte de un caso 前列腺原发性肺结核。报告个案
Q4 Medicine Pub Date : 2016-07-01 DOI: 10.1016/j.uromx.2016.02.008
L. Almazán-Treviño , M.A. Reyes-Gutiérrez , J.I. Monjarás-Guerra. , J.A. Rodriguez-Robles , M.M. Hernández-González , J.E. Rosas-Nava

Background

Tuberculosis is one of the diseases in which poverty, overcrowding, and malnutrition result in a poor immunologic state. Genitourinary tuberculosis is the most common extra-pulmonary site of tuberculosis, but involvement of the prostate gland is observed in only 2.6% of the cases.

Aim

To present a case of tuberculosis of the prostate and its medical and surgical management.

Case presentation A 63-year-old man had a history of intense smoking and occasional drinking and he sought medical attention for acute urinary retention. He had a prostate-specific antigen level of 1.36 ng/ml. Examination identified a 3 × 3 cm, hard, irregular prostate that was not painful upon palpation. Malignancy was suspected and the patient underwent a prostate biopsy that reported chronic granulomatous prostatitis. Studies for pulmonary or genitourinary disease were negative. Immunofluorescence corroborated the diagnosis of tuberculosis of the prostate. Anti-tuberculosis treatment was begun and continued for 6 months, after which transurethral resection of the prostate was performed.

Discussion

Primary tuberculosis of the prostate resembles different pathologies, such as prostate cancer and acute or chronic prostatitis, and therefore ultrasound-guided transrectal biopsy is indicated. The definitive diagnosis is made through histopathologic confirmation of the bacillus to differentiate it from nonspecific granulomatous prostatitis. Endourologic surgery is not contraindicated for this pathology.

结核病是一种贫穷、过度拥挤和营养不良导致免疫状态低下的疾病。泌尿生殖系统结核是肺结核最常见的肺外部位,但累及前列腺的病例仅占2.6%。目的介绍1例前列腺结核及其内科和外科治疗。病例介绍一名63岁男性,有重度吸烟和偶尔饮酒史,因急性尿潴留求医。前列腺特异性抗原1.36 ng/ml。检查发现一个3 × 3厘米,坚硬,不规则的前列腺,触诊无痛。怀疑为恶性肿瘤,患者行前列腺活检报告慢性肉芽肿性前列腺炎。肺部或泌尿生殖系统疾病的研究均为阴性。免疫荧光证实前列腺结核的诊断。开始抗结核治疗并持续6个月,之后行经尿道前列腺切除术。原发性前列腺结核类似于不同的病理,如前列腺癌和急性或慢性前列腺炎,因此需要超声引导下的经直肠活检。明确的诊断是通过组织病理学证实的芽孢杆菌,以区分它与非特异性肉芽肿性前列腺炎。对于这种病理,腔内外科手术不是禁忌。
{"title":"Tuberculosis primaria de la próstata. Reporte de un caso","authors":"L. Almazán-Treviño ,&nbsp;M.A. Reyes-Gutiérrez ,&nbsp;J.I. Monjarás-Guerra. ,&nbsp;J.A. Rodriguez-Robles ,&nbsp;M.M. Hernández-González ,&nbsp;J.E. Rosas-Nava","doi":"10.1016/j.uromx.2016.02.008","DOIUrl":"10.1016/j.uromx.2016.02.008","url":null,"abstract":"<div><h3>Background</h3><p>Tuberculosis is one of the diseases in which poverty, overcrowding, and malnutrition result in a poor immunologic state. Genitourinary tuberculosis is the most common extra-pulmonary site of tuberculosis, but involvement of the prostate gland is observed in only 2.6% of the cases.</p></div><div><h3>Aim</h3><p>To present a case of tuberculosis of the prostate and its medical and surgical management.</p><p>Case presentation A 63-year-old man had a history of intense smoking and occasional drinking and he sought medical attention for acute urinary retention. He had a prostate-specific antigen level of 1.36<!--> <!-->ng/ml. Examination identified a 3<!--> <!-->×<!--> <!-->3<!--> <!-->cm, hard, irregular prostate that was not painful upon palpation. Malignancy was suspected and the patient underwent a prostate biopsy that reported chronic granulomatous prostatitis. Studies for pulmonary or genitourinary disease were negative. Immunofluorescence corroborated the diagnosis of tuberculosis of the prostate. Anti-tuberculosis treatment was begun and continued for 6 months, after which transurethral resection of the prostate was performed.</p></div><div><h3>Discussion</h3><p>Primary tuberculosis of the prostate resembles different pathologies, such as prostate cancer and acute or chronic prostatitis, and therefore ultrasound-guided transrectal biopsy is indicated. The definitive diagnosis is made through histopathologic confirmation of the bacillus to differentiate it from nonspecific granulomatous prostatitis. Endourologic surgery is not contraindicated for this pathology.</p></div>","PeriodicalId":34909,"journal":{"name":"Revista mexicana de urologia","volume":"76 4","pages":"Pages 245-249"},"PeriodicalIF":0.0,"publicationDate":"2016-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.uromx.2016.02.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133459026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Revista mexicana de urologia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1